Valley Medical Pharmacy 
630 Main Street 
Brawley, CA 92227 
eRx ID#0585957 
1 (800) 322-0808 | Toll Free Fax: 1 (855) 322-0808 
Email: drugsdepot@yahoo.com 
Web: www.drugsdepot 
Timing: Monday to Friday | 9:00 AM to 5:45 PM 


Emla Cream 30 Gm By Actavis Pharma

Image 0 of Emla Cream 30 Gm By Actavis Pharma

Emla Cream 30 Gm By Actavis Pharma

Call for Price

Emla Cream 30 Gm By Actavis Pharma This Item Requires A Valid Order From A Physician Licensed in USA. Item Number.:RXB10112310/RXD4814109
Size : 30 GM
Selling UoM : EA
NDC: 76478-0289-30
UPC Barcode : 376478289309
Supplier: 0050000680 ACTAVIS PHARMA INC/BRAND
Supplier Material : 028930
Generic Code : 035495 LIDOCAINE/PRILOCAINE TOPICAL CREAM (G) 2
Fine Line Class : 850085008510 All Rx Products
Product Category : RX Pharmaceuticals
Product Type : BRX Branded RX

Have a question?

  Call for Price

Product Description.:

EMLA (Eutectic Mixture of Local Anesthetics) is a 1:1 oil/water emulsion of a eutectic mixture of lidocaine and prilocaine bases. Dermal analgesia is a result of the migration of lidocaine and prilocaine into the epidermal and dermal layers of the skin followed by the accumulation of these agents in the vicinity of dermal pain receptors and nerve endings. Lidocaine and prilocaine are both amide-type local anesthetic agents. They stabilize the neuronal membrane preventing the initiation and conduction of nerve impulses, thereby effecting local anesthetic action. EMLA provides dermal analgesia the depth of which depends upon the application time and the applied dose. Analgesia may be less for deeper structures.

Click Here for Prescribing Information

Indications And Clinical Uses: Cream: Topical analgesia of intact skin in connection with needle insertion, e.g., i.v. catheters or prior to blood sampling superficial surgical procedures, e.g., removal of molluscum contagiosum, split-skin grafting, electrolysis laser treatment.

Topical analgesia of genital mucosa in connection with: local infiltration anesthesia surgical procedures lasting not longer than 10 minutes on small superficial localized lesions, e.g., removal of condylomata by laser or cautery, and biopsies.

Topical analgesia of leg ulcers in connection with: mechanical cleansing/debridement, e.g., the removal of necrotic tissue and debris by curettes, scissors, tweezers, etc.

Patch: Topical analgesia of intact skin in connection with: needle insertion, e.g., i.v. catheters or prior to blood sampling.

Contra-Indications: Patients who are hypersensitive to local anesthetics of the amide type or to any other component of the product (see Supplied) with congenital or idiopathic methemoglobinemia who are less than 6 months of age, until further clinical data are available children between 6 to 12 months requiring treatment with methemoglobin-inducing agents e.g., sulfonamides.

Precautions: Due to insufficient data on absorption, EMLA should not be applied to open wounds as a result of trauma. Note: Leg ulcers often follow a slight trauma but are not classified as traumatic wounds.

Care should be taken when applying EMLA to patients with atopic dermatitis. A more rapid and greater absorption through the skin is observed in these patients. A shorter application time should be used (see Pharmacology). Sufficient data regarding absorption and local reactions are not available at present. Clinical data to permit dosage recommendations are also not available.

EMLA should not be applied to or near to the eyes as it causes corneal irritation. This reaction may be reversible. Damage to the eye may also occur from undetected foreign bodies.

Special care should be employed to reduce the risk of rubbing the eye with EMLA. Special care should also be employed to ensure the occlusive bandage or patch is secure. This will avoid accidental dislocation and exposure of EMLA, especially in young children.